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Abstract  To detect and characterize Chlamydia trachomatis (C. trachomatis) genotypes in infert ile  patients of Córdoba, 
Argentina; 660 endocervical and urethral swabs and semen samples were co llected from infert ile patients for detection of C. 
trachomatis by omp A gene with Hemi Nested-PCR and cryptic plasmid-PCR. Sequencing methods of omp A  gene were used 
to identify C. trachomatis genotypes. The sequences obtained were aligned with chlamydial sequences currently available in 
the GenBank, for the design of the phylogenetic tree. The prevalence of C. trachomatis was 7.27% (48/660). We did not 
detect C. trachomatis cryptic plasmid free strains. According to the results of nucleotide sequences, the distribution of 
genotypes was L1 (50 %) followed by G (25 %), E (12.5%) and D (12.5%). Patients who tested positive to genotype L1 had 
no symptoms of lymphogranuloma venereum (LGV). This is the first study that provides informat ion about the distribution 
of C. trachomatis genotypes and the circulation of cryptic plasmid negative strains of C. trachomatis among patients with 
infert ility in Córdoba, Argentina. 
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1. Introduction 
Chlamydia trachomatis (C. trachomatis) is the most 
prevalent bacteria in sexually  transmitted infections (STI) 
and can result in severe genital and ocular diseases[8]. The 
WHO has estimated 100 annual million new cases 
worldwide; however, most of the women with lower genital 
tract infections remain asymptomatic and therefore, 
undiagnosed[17]. 
The primary  sites of C. trachomatis infections are female 
endocervix and urethra of both genders. In men, C. 
trachomatis is associated with non-gonococcal urethritis 
and epididymitis[6]; in women, this pathogen can lead to 
serious complications such as endometrit is, salpingitis, 
pelvic inflammatory disease, ectopic pregnancy or tubal 
factor infertility[1, 26]. However, many patients remain 
asymptomatic and develop persistent infections, which can 
lead to severe reproductive sequelae[13]. Infertility due to C. 
trachomatis represents a preventable disease when is 
detected early on[21]. 
C. trachomatis possesses a cryptic 7.5-kb p las mid  of 
unknown function that  is  a p referred  target  fo r various  
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nucleic acid amplification tests, since it contains multip le 
copies. However, among C. trachomatis strains, 22 p lasmid 
free variants have been described; therefore, it is possible to 
obtain false negative results when cryptic plasmid PCR is 
the only test used [20]. 
C. trachomatis strains are currently classified into 
genotypes using polymerase chain reaction-restriction 
fragment length polymorphis m (PCR-RFLP) or sequencing 
of the ompA gene, which encodes the major outer 
membrane protein (MOMP). Genotypes A-C cause primary 
trachoma/blindness, D–K produce urogenital infect ions and 
L1–3 are responsible for invasive lymphogranuloma 
venereum (LGV)[15]. Genotypic characterization of C. 
trachomatis isolates can not only provide valuable insights 
into circu lating C. trachomatis genotypes within a given 
community, but also improve understanding of their 
epidemiology, which may assist in developing new 
strategies for improving STI control[4, 12]. 
In Argentina, the distribution of genotypes in patients 
with infert ility is still unknown. The aim of th is study was 
to detect and characterize Chlamydia trachomatis (C. 
trachomatis) genotypes in patients with infert ility in 
Córdoba, Argentina. We consider that this study is 
important to contact tracing and monitoring, to enable 
associations with clinical manifestations or pathogenicity 
and that it may also play a role in developing strategies for 
vaccine design. 
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2. Materials and Methods 
2.1. Clinical Samples  
Six hundred and sixty urogenital specimens were 
collected from adult patients (439 women and 221 men; 
mean age: 36.7 years[r=21-55]) who consulted for infert ility 
at private breed ing centers of Cordoba city, Argentina, 
between January and July, 2012. Samples were classified in: 
cervical swabs (CS) (n : 437), urethral swabs (US) (n: 5), 
urethral swabs with semen (US+S) (n: 148) and semen 
samples (n: 70). All of them were obtained by health care 
professionals and placed in sterile tubes containing 1 ml of 
SPG (sucrose, phosphate, glutamic acid), and subsequently 
sent to the Instituto de Viro logía, Facultad de Ciencias 
Médicas, Universidad Nacional de Córdoba, Argentina. 
Inclusion criteria: adult patients of both genders who 
complained of impaired fertility. Exclusion criteria: 
pregnant women, immunocompromised patients. 
The project was approved by the Ethics Committee 
C.E.I.E.S. Oulton-Romagosa, Córdoba and all patients 
signed written informed consent before entering the study. 
2.2. DNA Extraction 
200 μl of each sample were subjected to DNA ext raction 
using the Accuprep Genomic DNA Extract ion Kit 
(BIONEER, Alameda, CA, USA) according to the 
manufacturer’s instructions. 
2.3. OmpA gene Hemi Nested PCR 
PCR DNA ext ract (5 μl) was used to amplify a 1045 pb 
fragment of the ompA gene of C. trachomatis, using primers 
SeroA1 (5’ATGAAAAAACTCTTGAAATCGG3’) and 
SeroA2 (5’TTTCTAGAT/ CTTCATT/CTTGTT3´); in the 
nested PCR, it  was replaced by the first SeroA1 by PCTM3 
(5’TCCTTGCAAGCTCTGCCTGTGGGGAATCCT3’). 
Both PCR amplification processes commenced with a 
4-minute denaturation step at 95°C and continued with 49 
amplification cycles. Each cycle consisted of a first 
denaturation step at 95°C for 1 min, an annealing step at 
55°C for 1 min and a final step of chain elongation at 72° C 
for 1.5 min.[16]. 
2.4. Cryptic Plasmid PCR 
The primers used to generate a 201-bp fragment from the 
cryptic plas mid of C. trachomatis were CTP1 (5'-TAGTAA
CTGCCAClTCATCA -3') and CTP2 (5'-TTCCCCTTGTAA
TTCGTTGC-3'). The PCR amplification consisted of DNA 
denaturation at 95°C fo r 4 min followed by 35 cycles of 
amplification with a thermocycler Model One, Germany. 
Each cycle consisted of 1 min  at 95°C, 1 min at 55°C and 
1.5 min at 72°C followed by a final elongation at 72°C for 4 
min. The ompA gene and cryptic p lasmid PCR products 
were visualized after electrophoresis in a 1% agarose gel by 
ethidium bromide staining[16]. 
2.5. Sequencing of the omp A gene 
For sequence analysis, the nested-PCR products were 
purified with the QIAquick Gel Ext raction Kit (Qiagen, 
Valencia, CA, US) and subjected to direct nucleotide 
sequencing reaction in  both directions using an ABI 
automatic sequencer. The sequences were analyzed using 
the Molecular Evolutionary Genetics Analysis software 
package, MEGA4[25]. Sequences of the ompA derived 
from strains used in this study were analyzed along with the 
next sequences from strains available in GenBank: 
F/IU-IC0398cx (accession number FJ261947.1), E/UW-5 
(HQ637270.1), E/IU-FQ1138 (FJ261931.1), G/IU-FW0267 
(FJ261928.1), G/IU-TC0398cx (FJ261947.1), L1/440 
(DQ064294.1), L2/434 (DQ064295.1), L3/404 
(DQ064296.1), D/IU-FW0353 (FJ261929.1), D43nl 
(JN795446.1), K/UW-31 (DQ064293.1), H/580 
(DQ064289.1), Ia/IU-IC0018ut (FJ261940.1), J-27 
(JN795448.1), A/Har-1 (DQ064279), B3/IU-FQ0279 
(FJ261925.1) and the tree was rooted with the ompA 
sequence of the Chlamydia suis (C. suis) strain (accession 
number AF26273.1). Phylogenetic tree was constructed 
using the neighbor-joining method[24]. Branching pattern 
confidence levels were estimated by the bootstrap 
resampling of the data based on 1000 random replicates. 
2.6. Statistical Analysis 
Statistical analysis was performed using Chi-square or 
Fisher exact test. P value lower than 0.05 was considered 
statistically significant. Absolute and relative frequencies 
and 95% confidence intervals (CI) were g iven. 
3. Results 
C. trachomatis cryptic plasmid was detected by PCR in  
48/660 of the cases (7.27%), the prevalence was 7.52% 
(33/439) in  women and 6.79% (15/221) in  men. The 
difference was statistically significant p= 0.0003, OR= 3.81 
(1.67-8.96, CI 95%). The mean  age (years±SD) for infected 
men and women was 36.7±1.5 and 35.4±4.5, respectively. 
The percentage of detection in CS was 66.67% (32/48), 
while in US+S was 18.75% (9/48), only in semen 12.5% 
(6/48) and only in US 2.08% (1/48), being significantly 
higher (p<0.001) in samples from cerv ical swabs. In this 
study, C. trachomatis cryptic plasmid free strains were not 
detected. 
C. trachomatis was detected in 8/660 (1.21%) swabs and 
semen samples by ompA gene Hemi Nested-PCR. The 
prevalence of C. trachomatis in the female group was  
1.14% (5/439) and 1.38% (3/221) in males, with no 
statistically significant differences, p=0.8086, OR= 0.84 
(0.17-4.45, CI 95%). The genotypes identified by 
sequencing analysis were D 12,5% (1/8), E 12,5% (1/8), G 
25% (2/8), L1 50% (4/8). Genotype L1 was detected in 1 
CS, 1 US and 2 US+S;  genotypes E and G were detected in 
1 CS each one, while genotype D was found in 1 US+S 
(Table 1). 
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Infertility was the only symptom presented by C. 
trachomatis positive patients. 
The phylogenetic analysis confirmed that all the eight 
sequences clustered with C. trachomatis. The ompA 
sequences of the C. trachomatis strains were highly 
homologous and shared more than 98% similarity with each 
other. Blast searches revealed that ARG CA699 CT, ARG 
CA 042 CT, ARG CA 696 CT, ARG CA 043 CT ompA 
gene sequences showed high homology with L1 sequences. 
The CA 740 strain showed homology with other sequences 
of D genotypes, while ARG CA 534 CT revealed h igher 
homology with E genotypes; ARG CA 006 CT and ARG 
CA 159 CT presented some similarit ies when compared to 
G genotypes. According to the phylogenetic tree, genotypes 
were subdivided into three distinct groups, genotypes B, D, 
E, L1 and L2 comprised one group; F and G a second group, 
and A, C, H, Ia, J, K, and L3 constituted a third group (Fig. 
1). 
Table 1.  Description and distribution of C. trachomatis genotypes by gender, in samples of infertile patients 





D ARG 740 CT KC120819 D US+S M  0.94* 
     1(12.5)  
E ARG 534 CT KC120818 E CS F   
     1(12.5)  
G ARG 006 CT KC120825 G CS F   
G ARG 159 CT KC120822 G CS F   
     2 (25)  
L1 ARG 699 CT KC120820 L1 CS F   
L1 ARG 696 CT KC120821 L1 US F   
L1 ARG 042 CT KC120824 L1 US+S M   
L1 ARG 043 CT KC120823 L1 US+S M   
     4 (50)  
*Not statistically significant; F: females, M: males; CS: cervical swabs, US: urethral swabs, US+S: urethral swabs with semen 
 
Figure 1.  The neighbor-joining method was used in MEGA4 to generate phylogenetic trees for ompA from DNA sequences (900bp). Relevant bootstrap 
values (as a percentage of 1000 replicates) are provided. Initial nucleotide alignments generated with strains that belong to this study are initiated by ARG 
CA 
  




In this study, we found that the detection of C. 
trachomatis cryptic plasmid (7.27%) was significantly 
higher (p<0.0001) than omp A C. trachomatis (1.21%) gene 
Hemi Nested PCR; these results were associated to the 
highest sensitivity of the cryptic plasmid  PCR. It  has been 
demonstrated that during the chlamydial developing cycle, 
up to 7.6 plasmids per chromosome can be detected, 
indicating an increased plasmid copy number in the act ively 
replicat ing reticulate body [23]. The strong selection to 
maintain the plas mid by human  chlamydial strains is related 
to its importance in the pathogenesis of human infections or 
diseases; however a fundamental ambiguity of C. 
trachomatis biology is the unknown function of cryptic 
7.5-kb plas mid[5]. In addition, we did not detect cryptic 
plasmid free strains; similarly, Cuffin i et al[7] found no 
such strain in a population of young asymptomatic people 
of Córdoba, Argentina. These results are important since the 
circulat ion of these variants is still unknown in most parts 
of the world. 
The prevalence of cryptic plasmid C. trachomatis was 
7.52% in women and 6.79% in men. Our results are similar 
(percentage, studied population and methods) to a study 
performed in Poland, which reports a prevalence of 8.3% in 
women with infert ility[27]. In American subjects, a study 
published last year in Mexico[9] described a prevalence of 
15.8 % in women with infertility. Nevertheless, higher 
prevalence rates (43.3%) have been reported for 
asymptomatic male partners of infert ile couples in Africa, 
Tunisia[13] and infert ile  women of Brazil (52.8%)[18]. The 
high prevalence may be explained because these patients 
had previous history of STI. In  Córdoba, the prevalence of 
C trachomatis registered in asymptomatic sexually active 
young people and adolescents in 2008 was 8.7% (women: 
13.7%, men: 4.1%) [10]. However, we detected a lower 
prevalence in our population of patients with infertility. 
This may be due to differences on the age range of the 
studied groups. Also, we lack information about the fert ility 
status of the group of young people analyzed in the previous 
study. 
In this study, we also present the genotype distribution of 
C. trachomatis in these patients. Eight (8/600) C. 
trachomatis-positive samples were classified by 
phylogenetic analysis, demonstrating the presence of 
genotypes L1 (4/8), G (2/8), D (1/8) and E (1/8). The 
prevalence of C. trachomatis genotypes has been identified 
in several countries, with the genotype D (5-48%), D 
variants, E (22-44%) and F (8-20%) predominating in 
urogenital infect ions, while G (4-7%), Ga, H (<5%), I (6%), 
I variants, J (5-13%), and K (5-10%) were less common. 
Sporadically, genital infections with genotypes B and Ba 
also occur.[9, 19, 11, 15]. There are not many 
Latin -American studies of the distribution of C. trachomatis 
genotypes in infertile patients. A recent study in Mexico[9] 
pointed genotypes F (54.2%), E (8.7%), G (8.7%) and L2 
(8.7%) as the most frequently found in women with 
infert ility. In this study, we found genotypes E and D, and 
other genotypes less common, such as G and L1. Genotypes 
E and G were only found in women (12.5% and 25%, 
respectively) and genotype D was only detected in  men 
(12.5%). L1 was found in  both sexes but presented a higher 
proportion in men (12.5% vs. 37.5%). In  Córdoba, a 
previous study in asymptomatic adolescents and young 
people pointed genotype E as the most common (57.14 of 
73%) in women, fo llowed by genotype D (16.2%); 
genotypes F and G were detected in lower proportion (5.4%) 
in both genders[7]. The same genotypes E, D and F were 
found in Buenos Aires city by Gallo Vaulet et al[11] in 
asymptomatic women, with a p revalence of 46.9%, 21% 
and 16.1%, respectively. We also detected circulat ion of 
genotype E in infert ile  patients, although in lower 
proportion than Cuffin i et al[7]. We consider that this may 
be due to different characteristics of the studied groups (age, 
infert ility). Surprisingly, we detected a high proportion (4/8) 
of L1 genotype in patients without symptoms of LGV, 
similarly to De Haro-Cruz et al, in Mexico[9], who also 
detected the genotype corresponding to LGV by 
phylogenetic analysis. 
Interestingly, the phylogenetic analysis showed three 
subdivisions, but the main branches did not coincide with 
the tissue tropisms and patterns of clinical presentation 
associated with C. trachomatis infection in human hosts. 
Identical results were obtained by Brunelle and Sensabaugh, 
and Lutter[2, 3, 19] in the phylogenetic characterization of 
the ompA gene. It has been proposed that the variability of 
MOMP is due to the antigenicity of MOMP and selective 
pressure of the immune system and as a result, the 
phylogeny of MOMP is not in agreement with t issue 
tropism or disease[19]. 
C. trachomatis is a  prevalent sexually transmitted 
infection that can lead to serious reproductive morbid ity. 
The management and control of C. trachomatis is a 
challenge, largely due to its asymptomatic nature and our 
incomplete understanding of its natural history. Although 
chlamydia screening programs have been implemented 
worldwide, several countries have observed increasing rates 
of reported chlamydia new cases[26]. In conclusion, this is 
the first article from this region showing the prevalence rate 
of C. trachomatis infection in infertile  patients and provides 
informat ion on circulating genotypes. In addit ion, we 
demonstrated the absence of detection of cryptic plasmid 
free strains in this population in Cordoba; this constitutes an 
important data in the routine diagnosis. Local data also 
supports the need of a more extensive screening for 
infert ility caused by C. trachomatis in Cordoba, with the 
intention of early detection, treatment and prevention. 
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